HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caron A Jacobson Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

12/2023Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
12/2023Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia.
12/2023Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
1/2023Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
11/2020C(h)AR-ting a new course in incurable lymphomas: CAR T cells for mantle cell and follicular lymphomas.
1/2020KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
1/2020Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphoma.
1/2019Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1-1b study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caron A Jacobson Research Topics

Disease

31B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 12/2017
18Lymphoma (Lymphomas)
02/2024 - 01/2017
14Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2024 - 09/2012
14Neoplasms (Cancer)
11/2023 - 01/2017
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2024 - 12/2017
10Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2023 - 01/2019
8Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2023 - 01/2019
7Disease Progression
02/2024 - 01/2019
7Cytokine Release Syndrome
01/2024 - 01/2019
6Residual Neoplasm
01/2024 - 08/2019
5Leukemia
12/2023 - 11/2016
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2024 - 01/2016
4Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 01/2019
4Hodgkin Disease (Hodgkin's Disease)
12/2022 - 01/2012
3cell-associated neurotoxicity
10/2023 - 11/2022
3Infections
01/2019 - 04/2012
3Bronchiolitis Obliterans Syndrome
05/2014 - 11/2010
2Multiple Myeloma
01/2023 - 11/2022
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2023 - 09/2010
2Body Weight (Weight, Body)
01/2020 - 12/2017
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2023
1Neurotoxicity Syndromes (Toxic Encephalopathy)
11/2023
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2023
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2023
1Heart Failure
01/2023
1Neutropenia
11/2022
1Cytopenia
11/2022
1Mycoses (Diseases, Fungus)
01/2022
1Tumor Lysis Syndrome
01/2022
1Spinal Cord Diseases
12/2021
1Pathologic Complete Response
10/2021
1Carcinogenesis
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2020
1Inflammation (Inflammations)
10/2020
1Hypokalemia
01/2020
1Hyponatremia
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Cardiac Sudden Death (Sudden Cardiac Arrest)
08/2019
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Atrial Fibrillation
01/2019

Drug/Important Bio-Agent (IBA)

39Chimeric Antigen ReceptorsIBA
04/2024 - 12/2017
29axicabtagene ciloleucelIBA
04/2024 - 12/2017
4tocilizumab (atlizumab)FDA Link
01/2024 - 01/2019
4ibrutinibIBA
01/2024 - 01/2019
4Rituximab (Mabthera)FDA Link
01/2024 - 01/2016
4Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2016
3AnthracyclinesIBA
02/2024 - 01/2019
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024 - 01/2019
3fludarabineIBA
01/2024 - 12/2017
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024 - 12/2017
3tisagenlecleucelIBA
10/2023 - 12/2019
3Bendamustine HydrochlorideFDA Link
10/2023 - 01/2016
3pembrolizumabIBA
01/2023 - 01/2019
3venetoclaxIBA
01/2022 - 12/2019
3idelalisibIBA
12/2019 - 01/2016
2Atorvastatin (Lipitor)FDA Link
02/2024 - 01/2023
2Immunoglobulins (Immunoglobulin)IBA
12/2023 - 12/2022
2brexucabtagene autoleucelIBA
01/2023 - 01/2020
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2023 - 11/2022
2Monoclonal AntibodiesIBA
01/2022 - 01/2019
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2020 - 01/2019
2Lenalidomide (CC 5013)FDA Link
12/2019 - 01/2016
1defibrotideIBA
11/2023
1AntibodiesIBA
10/2023
1utomilumabIBA
10/2023
1serum P-component (CIt)IBA
02/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2022
1PNT100IBA
01/2022
1Alkylating AgentsIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1OligonucleotidesIBA
01/2022
1A-Form DNA (A-DNA)IBA
01/2022
1siltuximabIBA
12/2021
1acalabrutinibIBA
10/2021
1obinutuzumabIBA
10/2021
1Nuclear Proteins (Protein, Nuclear)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Antigen Receptors (Antigen Receptor)IBA
01/2021
1polatuzumab vedotinIBA
01/2021
1RO6870810IBA
01/2021
1Tolnaftate (Ting)IBA
11/2020
1ElectrolytesIBA
01/2020
1tazemetostatIBA
12/2019
1Immunomodulating AgentsIBA
12/2019
1Enhancer of Zeste Homolog 2 ProteinIBA
12/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2019
1Lipase (Acid Lipase)FDA Link
01/2019

Therapy/Procedure

47Therapeutics
03/2024 - 11/2010
15Drug Therapy (Chemotherapy)
02/2024 - 01/2017
14Stem Cell Transplantation
12/2023 - 01/2017
7Immunotherapy
11/2023 - 01/2018
3Transplantation
12/2019 - 04/2012
2Blood Component Removal (Apheresis)
12/2023 - 12/2022
2Cell Transplantation
11/2023 - 12/2019
2Radiotherapy
11/2023 - 09/2012
2Organ Transplantation
01/2023 - 09/2010
1Aftercare (After-Treatment)
01/2020